In the first trimester, monotherapy significantly reduced the odds of unfavorable outcomes (OR 4.8, p = 0.025), while combination therapy showed a protective trend that did not reach statistical significance (OR 4.4, p = 0.051).
← all excerpts
Pregnancy Outcomes and Disease Activity in Women With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study.
1
0.0510
0.0510